Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01721304 · ClinicalTrials.gov registry record · NA
Decisionmaking for Abnormal Uterine Bleeding (AUB)
A NA study of Abnormal Uterine Bleeding, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 380
- Enrollment target
- 2
- Study locations
NCT01721304 is a NA study of Abnormal Uterine Bleeding that has completed, run by Indiana University. The registered enrollment target is 380 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT01721304, a NA study of Abnormal Uterine Bleeding, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 380 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine if using a computer survey about preferences for treatment of abnormal uterine bleeding (AUB) is useful and if it will improve patient satisfaction with clinical care and decision making. This study is a two-part study. The first pilot tests the computerized tool to ensure it is understood by patients, then the second part is a randomized study (computerized tool versus usual care) to see if improvements are made in satisfaction and if there are reductions in decision regret.
Conditions Studied
Interventions
- OTHER Adaptive Conjoint Analysis
Study Locations (2)
Indiana
- Indiana University - Indianapolis
North Carolina
- Southern Pines Women's Health Center - Southern Pines
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 380 participants |
| Start Date | 2009-05 |
| Est. Completion | 2012-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01721304
The ClinicalTrials.gov registry entry for NCT01721304 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 380 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Abnormal Uterine Bleeding appearing as the primary indexed condition, and to 1 intervention - of which Adaptive Conjoint Analysis is the first listed.
NCT01721304 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Indiana, North Carolina.
Frequently Asked Questions
What is clinical trial NCT01721304 about?
NCT01721304 is a clinical study titled "Decisionmaking for Abnormal Uterine Bleeding (AUB)". The purpose of this study is to determine if using a computer survey about preferences for treatment of abnormal uterine bleeding (AUB) is useful and if it will improve patient satisfaction with clinical care and decision making. This study is a two-part study. The first pilot tests the computerized...
What is the current status of trial NCT01721304?
This trial is currently completed. It is a NA study. The enrollment target is 380 participants. The study started on 2009-05. Estimated completion is 2012-08.
What conditions does trial NCT01721304 study?
This clinical trial studies the following conditions: Abnormal Uterine Bleeding.
What interventions are being tested in trial NCT01721304?
The interventions under investigation include: Adaptive Conjoint Analysis (OTHER).
Who is sponsoring clinical trial NCT01721304?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01721304 being conducted?
This trial has 2 study locations across Indiana, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abnormal Uterine Bleeding
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.